EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Clinical response and tolerability of eslicarbazepine in treatment of partial onset seizures: impact of a novel metabolic pathway

Cynthia Harden, Enrique Serrano

Journal of Receptor, Ligand and Channel Research · 2011

DOI: 10.2147/jrlcr.s16729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Receptor, Ligand and Channel Research, 2011. Verfasst von Cynthia Harden und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Harden, C., & Serrano, E. (2011). Clinical response and tolerability of eslicarbazepine in treatment of partial onset seizures: impact of a novel metabolic pathway. Journal of Receptor, Ligand and Channel Research. https://doi.org/10.2147/jrlcr.s16729

Vancouver

Harden C, Serrano E. Clinical response and tolerability of eslicarbazepine in treatment of partial onset seizures: impact of a novel metabolic pathway. Journal of Receptor, Ligand and Channel Research. 2011. doi:10.2147/jrlcr.s16729

BibTeX
@article{Harden2011,
  author = {Harden, Cynthia and Serrano, Enrique},
  title = {Clinical response and tolerability of eslicarbazepine in treatment of partial onset seizures: impact of a novel metabolic pathway},
  journal = {Journal of Receptor, Ligand and Channel Research},
  year = {2011},
  doi = {10.2147/jrlcr.s16729}
}
Kostenlos starten →